Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Influenza and Other Respiratory Viruses|May 21, 2009
Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenzaChristopher S Ambrose, Catherine Luke, Kathleen Coelingh
Jvs-Vascular Science|December 26, 2022
Investigating the role of receptor interacting protein kinase 3 in venous thrombosisElise DeRoo, Mitri Khoury, Ting Zhou, et al.
Thrombosis Research|March 11, 2015
A histological and functional description of the tissue causing chronic postthrombotic venous obstructionAnthony J Comerota, Carson Oostra, Ziad Fayad, et al.
Msphere|December 5, 2025
Growth phase influences virulence in <i>Candidozyma auris</i> systemic infection modelsMichael J McFadden, Juliet A E Anku, Faith A Davis, et al.
The Journal of Infectious Diseases|December 15, 2015
Evaluation of the Safety and Immunogenicity of a Candidate Pandemic Live Attenuated Influenza Vaccine (pLAIV) Against Influenza A(H7N9)Mahdee Sobhanie, Yumiko Matsuoka, Sinthujan Jegaskanda, et al.
Journal of Vascular Surgery. Venous and Lymphatic Disorders|September 24, 2025
Predictive biomarkers for post-thrombotic syndromeOscar Moreno, Nathaniel Parchment, Kate Micallef, et al.
The Journal of Infectious Diseases|February 13, 2009
A live attenuated H9N2 influenza vaccine is well tolerated and immunogenic in healthy adultsRuth A Karron, Karen Callahan, Catherine Luke, et al.
Blood|August 25, 2023
The oxylipin analog CS585 prevents platelet activation and thrombosis through activation of the prostacyclin receptorLivia Stanger, Adriana Yamaguchi, Pooja Yalavarthi, et al.
Pageof 2